Data Element
Pathology Molecular Test Name
Description

Name of the molecular pathology test used as part of diagnosis and staging. There are a wide range of tests. In the case of prostate cancer values include:
DECIPHER
Prolaris
Oncotype DX Genomic Prostate Score
ProMark
Submitted By: Charles Mayo, PhD / University of Michigan
Data Element Information
Use Case Description(s)
Use Case Description Diagnosis and Staging are core components for all aspects of clinical care for cancer patients. It is also a core component for billing.
Estimate the breadth of applicability of the use case(s) for this data element All stakeholders capture diagnosis and staging data in electronic records systems. It is routinely exchanged among providers and insurers in determining the most appropriate approach to care. It is a required element in clinical and translational research identifying approaches optimizing patient outcomes.
Healthcare Aims
  • Improving patient experience of care (quality and/or satisfaction)
  • Improving the health of populations
  • Reducing the cost of care
  • Improving provider experience of care
Maturity of Use and Technical Specifications for Data Element
Applicable Standard(s) American Joint Committee on Cancer e.g. AJCC8
https://www.facs.org/quality-programs/cancer-programs/american-joint-committee-on-cancer/
Additional Specifications N/A
Current Use Extensively used in production environments
Extent of exchange 5 or more. This data element has been tested at scale between multiple different production environments to support the majority of anticipated stakeholders.
Potential Challenges
Restrictions on Standardization (e.g. proprietary code) No restrictions. Codes are publicly available and free to use.
Restrictions on Use (e.g. licensing, user fees) No restrictions. Codes are publicly available and free to use.
Privacy and Security Concerns None
Estimate of Overall Burden Minimal. Data is collected as part of routine practice.
ONC Evaluation Details
Each submitted Data Element has been evaluated based on the following criteria. The overall Level classification is a composite of the maturity based on these individual criteria. This information can be used to identify areas that require additional work to raise the overall classification level and consideration for inclusion in future versions of USCDI
Criterion #1
Maturity - Current Standards		 Level 2 - Data element is represented by a terminology standard or SDO-balloted technical specification or implementation guide.
Criterion #2
Maturity - Current Use 		Level 2 - Data element is captured, stored, or accessed in multiple production EHRs or other HIT modules from more than one developer.
Criterion #3
Maturity - Current Exchange		 Level 2 - Data element is electronically exchanged between more than two production EHRs or other HIT modules of different developers using available interoperability standards.
Criterion #4
Use Case(s) - Breadth of Applicability		 Level 0 - Use cases apply to a limited number of care settings or specialties, or data element represents a specialization of other, more general data elements.
Evaluation Comment This data element represents a subset of the more general data element Laboratory Tests https://www.healthit.gov/isa/taxonomy/term/676/uscdi-v3 in USCDI v3. As a discrete data element, it would have a narrower breadth of applicability than the more generally applicable Lab Tests data element.

Comment

Log in or register to post comments